BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3908235)

  • 1. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic pregnancies.
    Gerö G; Rákóczi I; Tihanyi K; Oláh J; Demeter J; Gáti I
    Haemostasis; 1985; 15(6):377-83. PubMed ID: 3908235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between the sensitivity of platelets to ADP and PGI2 in normal and diabetic pregnancies.
    Gerö G; Rákóczi I; Tihanyi K; Blaskó G; Oláh J; Sas G
    Thromb Res; 1985 Sep; 39(6):781-2. PubMed ID: 3909505
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
    Onodera H; Hirata T; Sugawara H; Sugai K; Yoda B; Toyota T; Goto Y
    Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet sensitivity to prostacyclin in pregnancy and uterine cancer.
    Briel RC; Lippert TH
    Eur J Obstet Gynecol Reprod Biol; 1981 Jun; 12(1):19-23. PubMed ID: 7018952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.
    Gisinger C; Schernthaner G
    Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB; Miller OV; Spillers C; Gorman RR
    Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
    Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical platelet behaviour in diabetic ketoacidosis.
    Campbell RR; Foster KJ; Stirling C; Mundy D; Reckless JP
    Diabet Med; 1986 Mar; 3(2):161-4. PubMed ID: 2951159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet sensitivity in vitro to adenosine-5'-diphosphate and prostacyclin and diabetic retinopathy.
    Davis TM; Bown E; Turner RC
    Diabetologia; 1985 May; 28(5):274-6. PubMed ID: 3894139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet sensitivity to a prostacyclin analogue in normal and pathological pregnancy.
    Briel RC; Kieback DG; Lippert TH
    Prostaglandins Leukot Med; 1984 Mar; 13(3):335-40. PubMed ID: 6201928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin formation by the pregnant human myometrium.
    Bamford DS; Jogee M; Williams KI
    Br J Obstet Gynaecol; 1980 Mar; 87(3):215-8. PubMed ID: 6992847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes.
    Rao GH; Reddy KR; White JG
    Prostaglandins Med; 1980 Jun; 4(6):385-97. PubMed ID: 6251492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet sensitivity to prostacyclin in diabetes mellitus.
    Pillay PK; Pillay U; Balasubramaniam P; Lee KO
    Ann Acad Med Singap; 1985 Apr; 14(2):229-31. PubMed ID: 3898978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets from diabetic subjects show diminished sensitivity to prostacyclin.
    Betteridge DJ; El Tahir KE; Reckless JP; Williams KI
    Eur J Clin Invest; 1982 Oct; 12(5):395-8. PubMed ID: 6816610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
    Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
    Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
    Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.
    Hassall DG; Owen JS; Bruckdorfer KR
    Biochem J; 1983 Oct; 216(1):43-9. PubMed ID: 6360159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
    Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G
    Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.